Vascular Closure Devices Market to Observe Strong Development by 2027

Page 1

Vascular Closure Devices Market: Introduction According to the report, the global vascular closure devices market was valued at US$ 0.8 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Vascular closure devices are a new technology that is paving the way to new arenas in interventional surgery. Prior to the adoption of vascular closure devices, mechanical and manual compression techniques were utilized to facilitate access site hemostasis. These techniques had some disadvantages such as patient discomfort, increased hospital stay, over utilization of hospital resources, and delayed ambulation time. Vascular closure devices ensure quick hemostasis and proper closure of access site. Major types of vascular closure devices are active approximators, passive approximators, and external hemostatic devices. Increasing prevalence of cardiovascular diseases, rise in number of cardiovascular procedures, and recent product approvals by regulatory authorities are the major factors anticipated to drive the global vascular closure devices market during the forecast period. North America held major share of the global market in 2018 due to development of technologically advanced products by leading players to address unmet needs and recent product approvals by the Food Drug Administration (FDA). Additionally, rapid adoption of minimally invasive procedures in cardiology is expected to support the growth of the market in North America during the forecast period. Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php? flag=B&rep_id=13565 The vascular closure devices market in Asia Pacific is likely to expand at a high CAGR of 8% from 2019 to 2027. Rise in number of healthcare providers offering minimally invasive treatment options for cardiac patients and increase in number of surgical procedures are expected to drive the market in the region. Rise in Number of Minimally Invasive Procedures to Drive Market Rise in number of minimally invasive surgical procedures across the world is projected to augment the global vascular closure devices market during the forecast period. As per the data by the Society of Thoracic Surgeons (ACC), transcatheter valve therapy (TVT) registry database, in the U.S., the number of TAVR procedures performed rose from 5,000 in 2012 to nearly 50,000 in 2017. Furthermore, adoption of minimally invasive heart surgeries is increasing due to an increase in awareness about these surgeries over traditional open surgeries. Passive Approximators Key Product in Vascular Closure Devices Market In terms of product, the market has been divided into passive approximators, active approximators and external hemostatic devices. The passive approximators segment has been further categorized into collagen plugs, sealant or gel-based devices, and compression-assist devices. The active approximators segment has been further divided into suture-based devices and clip-based devices. The passive approximators segment dominated the market in 2018 and the trend is projected to continue during the forecast period. Extensive use of passive approximators and number of manufacturers for passive approximators is anticipated to fuel the growth of the segment during the forecast period. Request for Analysis of COVID-19 Impact on Vascular Closure Devices Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=13565 Rise in Awareness about Femoral Access Vascular Closure Devices


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.